Study of Inactivated, Split-Virion Influenza Vaccine [2007-2008 formulation] and Standard Fluzone Vaccine in Adult and Elderly Subjects
Phase of Trial: Phase II
Latest Information Update: 17 May 2016
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi
- 10 Oct 2013 Primary endpoint 'Seroconversion-rate' has been met according to results published in Vaccine.
- 10 Oct 2013 Primary endpoint 'Geometric-mean-antibody-titre' has been met according to results published in Vaccine.
- 10 Oct 2013 Results published in Vaccine.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History